
Joseph Cook
Managing Director
Get their honest, personalized take on your startup.
Sign in to pitch Joseph →At a glance
- Full Name
- Joe Cook, III
- Title
- Managing Director & Co-Founder
- Firm
- Mountain Group Partners (MGP)
- Firm Type
- Venture Capital (early-stage; the firm also makes seed/angel-style investments)
- Investment Stage
- Seed, Series A, and early-stage venture (occasionally Series B)
- Check Size
- ~$100K–$5.0M, with a sweet spot around $1.5M (firm-level range)
- Target Company Profile
- Early-stage life sciences and health/diagnostics startups where the firm can "come early and stay late" as a long-term, operationally engaged investor
- Sector Focus
- Life sciences — diagnostics, medical devices/technology, drug development, animal health, and related biotech
- Geographic Focus
- United States, with a strong base in the Southeast / Nashville, Tennessee region
- Location
- Nashville, Tennessee (3835 Cleghorn Ave, Suite 300, Nashville, TN 37215)
Background
Joe Cook, III is a Managing Director and co-founder of Mountain Group Partners, a Nashville-based venture capital firm focused predominantly on early-stage life sciences. Within the firm's partnership — which includes his father and firm founder Joe Cook, Jr., along with Managing Directors such as Byron Smith and Rob Readnour — he specializes in diagnostics and medical technology. The firm describes him as someone with "the uncanny ability to see the big picture and to dive deep into numbers and details," reflecting a background that combines capital-markets discipline with hands-on sector focus.
Before co-founding Mountain Group Partners, Cook spent his early career in investment banking in Nashville. From January 2001 to February 2003 he was a director of private placements in the investment banking group at Robert W. Baird & Co. Prior to that, he was a Vice President in the investment banking group at the storied Nashville firm J.C. Bradford & Co., where he worked on private equity deal-making and capital-markets transactions. This banking foundation underpins his role leading and structuring MGP's early-stage investments.
Cook earned a Bachelor of Arts in economics from Davidson College. He is active in the regional life-sciences ecosystem, serving on the board of the Southeastern Life Sciences Association and on the advisory board of the Nashville Capital Network, in addition to multiple portfolio-company boards.
Mountain Group Partners has operated for roughly two decades and emphasizes being the largest investor in its own funds to align interests with its limited partners. In June 2022 the firm completed fundraising on its $128 million MGP Venture Fund III, extending its strategy of concentrated, long-horizon bets in underserved life-sciences niches.
Investment Thesis & Focus
- Invests primarily at the seed and Series A stage in life sciences — diagnostics, medical devices/technology, drug development, and animal health — with selective follow-on into later rounds.
- The firm's stated approach is to "come early and stay late": take meaningful early ownership, then provide long-term capital, operational expertise, and board-level engagement rather than passive checks.
- Check sizes at the firm level run roughly $100K to $5.0M, with a typical sweet spot near $1.5M.
- Favors disruptive technologies in underserved sectors, and aligns with its LPs by remaining the largest investor in its own funds.
- Cook personally concentrates on diagnostics and medical technology, bringing an investment-banking lens to deal structuring and capital strategy.
Notable Investments
- Circular Genomics — RNA-biomarker / precision-psychiatry diagnostics company; Cook serves on the board. Raised ~$8M (Jan 2024) and a ~$15M Series A (reported Dec 2025).
- Mindera (MiNDERA Corporation) — skin-genomics / non-invasive diagnostics company; Cook is a board member. Raised a ~$25M convertible note (Jul 2024).
- PinkDx — women's-health diagnostics company; ~$40M Series A (Apr 2024).
- Advanced Animal Diagnostics (AAD / QScout) — animal-health diagnostics company; Cook serves on the board of directors.
- Cerebrotech — medical-device company (cerebral fluid/edema monitoring); Cook serves on the board of directors.
- Appello Pharmaceuticals — drug-development company affiliated with the Cook family/MGP; ~$16M Series A (2018).
- Firm-level portfolio context: Mountain Group Partners' broader track record includes life-sciences companies such as Aspire Health, Castle Biosciences, G1 Therapeutics, and Silicon Ranch.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.